MARKET

NYMX

NYMX

Nymox
NASDAQ

Real-time Quotes | Nasdaq Last Sale

2.260
-0.005
-0.22%
Closed 16:00 12/13 EST
OPEN
2.200
PREV CLOSE
2.265
HIGH
2.350
LOW
2.200
VOLUME
103.75K
TURNOVER
--
52 WEEK HIGH
2.750
52 WEEK LOW
1.250
MARKET CAP
158.83M
P/E (TTM)
-13.2362
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of NYMX and other stocks commission-free!

Open a Webull account and fund it to get a free stock

NYMX News

  • CIEN, DBD, DPW and CEI among midday movers
  • Seeking Alpha - Article.1d ago
  • The Nymox Pharmaceutical (NASDAQ:NYMX) Share Price Is Up 172% And Shareholders Are Boasting About It
  • Simply Wall St..11/05 14:35
  • Nymox Reports on Newly Issued Patents and Corporate Developments
  • GlobeNewswire.10/21 14:30
  • Are Insiders Selling Nymox Pharmaceutical Corporation (NASDAQ:NYMX) Stock?
  • Simply Wall St..07/24 16:58

More

Industry

Biotechnology & Medical Research
-0.88%
Pharmaceuticals & Medical Research
+0.01%

Hot Stocks

Name
Price
%Change

About NYMX

Nymox Pharmaceutical Corp is a Canada-based biopharmaceutical company. The Company is focused on developing its drug candidate, NX-1207, for the treatment of benign prostatic hyperplasia (BPH) and the treatment of low-grade localized prostate cancer. The Company operates through the research and development of products for the aging population segment. The Company markets NicAlert and TobacAlert tests that use urine or saliva to detect use of tobacco products. The Company also owns rights for its marketed products, its investigational drug, as well as other therapeutic and diagnostic indications. The Company also has the rights for the use of statin drugs for the treatment and prevention of Alzheimer's disease. The Company's subsidiaries include Nymox Corporation and Serex, Inc. Nymox Corporation conducts research and development, while Serex, Inc. conducts research and development, and manufacturing of NicAlert and TobacAlert.
More

Webull offers Nymox Pharmaceutical Corp (NYMX) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.